SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries to subscribe 100% stake in Ratna Lifesciences

03 Aug 2023 Evaluate

Sudarshan Pharma Industries has entered into an agreement for subscription of shares of Ratna Lifesciences equivalent to 100% of the shareholding of the Company as wholly owned subsidiary Company, as on date August 02, 2023, representing 100% holding in Ratna Lifesciences. The cost of acquisition will be Rs 550 lakh. 

Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.

Sudarshan Pharma Ind Share Price

30.33 -0.57 (-1.84%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×